OOIR: Observatory of International Research

Papers

(The H4-Index of Journal of Autoimmunity is 38. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2022-06-01 to 2026-06-01.)

Article	Citations
Janus kinase inhibition prevents autoimmune diabetes in LEW.1WR1 rats	441
Safety of biologic immunosuppressants in pregnant women with immune-mediated inflammatory diseases	175
Advances in SLE classification criteria	159
Striatin-3 is a human autoantigen but it is not associated with the S-phase G2 nuclear antigen (SG2NA) staining pattern	151
HNF4α, SP1 and c-myc are master regulators of CNS autoimmunity	125
ATP-binding cassette G1 membrane transporter-mediated cholesterol efflux capacity influences coronary atherosclerosis and cardiovascular risk in Rheumatoid Arthritis	121
GILZ regulates type I interferon release and sequesters STAT1	119
The universal effects of low-dose interleukin-2 across 13 autoimmune diseases in a basket clinical trial	117
Immunological and fibrotic profiling in the NOD.c3c4 murine model of autoimmune cholangitis	106
Ectopic CD4+ T cells in choroid plexus mediate neuropsychiatric lupus symptoms in mice via interferon-γ induced microglia activation	106
Autoimmune associated HLAs and T cell autoantigens exhibit common patterns across several autoimmune diseases	100
Autoreactivity to self-antigens LL37 and ADAMTSL5 influences the clinical response to risankizumab in psoriatic patients	85
Differences in innate immune cell populations distinguish autoimmune from herpesvirus-associated encephalitis	85
Breach of tolerance versus burden of bile acids: Resolving the conundrum in the immunopathogenesis and natural history of primary biliary cholangitis	83
Editorial Board	64
Tfh cell-derived small extracellular vesicles exacerbate the severity of collagen-induced arthritis by enhancing B-cell responses	63
Disease activity in patients with immune-mediated inflammatory diseases after SARS-CoV-2 vaccinations	61
PAD2-mediated citrullination of MBP and early myelin destabilization in multiple sclerosis	61
Lupus nephritis: new progress in diagnosis and treatment	60
Global and regional epidemiology of psoriatic arthritis in patients with psoriasis: A comprehensive systematic analysis and modelling study	60
Anti-annexin A4 antibody as a biomarker for desquamative interstitial pneumonia	59
Editorial Board	59
Editorial Board	58
LAT1 enables T cell activation under inflammatory conditions	57
Post-translationally modified proteins bind and activate complement with implications for cellular uptake and autoantibody formation	52

Targeting macrophages with phosphatidylserine-rich liposomes as a potential antigen-specific immunotherapy for type 1 diabetes	52
Sunscreen use associated with elevated prevalence of anti-nuclear antibodies in U.S. adults	48
Editorial Board	46
Free water in the hippocampal cingulum as a Radiomic biomarker for Identifying inflammatory neuropsychiatric Lupus: A cross-sectional case-control study	46
Identification of the central tolerance checkpoint for autoreactive proteinase 3+ B cells in human bone marrow	45
Deciphering Sjögren's disease: New insights and perspectives extend from advanced omics approaches and immunology	43
Mitochondrial dysfunction is a potential key mechanism for atherosclerosis predisposition in patients with systemic lupus erythematosus	42
FAPI PET/CT for tracking disease trajectory in myositis-related interstitial lung disease	41
Earlier vs. later time period of COVID-19 infection and emergent autoimmune signs, symptoms, and serologies	41
Autoantibodies against a subunit of mitochondrial respiratory chain complex I in inclusion body myositis	40
Proinflammatory CD20+CD3+ T cells as a potential driver of macrophage reprogramming in rheumatoid arthritis	38
Whole blood transcriptome identifies interferon-regulated genes as key drivers in thrombotic primary antiphospholipid syndrome	38
Cellular communication network factor 3 contributes to the pathological process of rheumatoid arthritis through promoting cell senescence and osteoclastogenesis in the joint	38
The complement system and human autoimmune diseases	38